These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 34961893)

  • 1. Transcriptomic analysis of frontotemporal lobar degeneration with TDP-43 pathology reveals cellular alterations across multiple brain regions.
    Hasan R; Humphrey J; Bettencourt C; Newcombe J; ; Lashley T; Fratta P; Raj T
    Acta Neuropathol; 2022 Mar; 143(3):383-401. PubMed ID: 34961893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of TMEM106B, the frontotemporal lobar degeneration-associated protein, in normal and diseased human brain.
    Busch JI; Martinez-Lage M; Ashbridge E; Grossman M; Van Deerlin VM; Hu F; Lee VM; Trojanowski JQ; Chen-Plotkin AS
    Acta Neuropathol Commun; 2013 Jul; 1():36. PubMed ID: 24252750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of cerebellar TDP-43 loss of function in FTLD-TDP.
    Pickles S; Gendron TF; Koike Y; Yue M; Song Y; Kachergus JM; Shi J; DeTure M; Thompson EA; Oskarsson B; Graff-Radford NR; Boeve BF; Petersen RC; Wszolek ZK; Josephs KA; Dickson DW; Petrucelli L; Cook CN; Prudencio M
    Acta Neuropathol Commun; 2022 Jul; 10(1):107. PubMed ID: 35879741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with sporadic FTLD exhibit similar increases in lysosomal proteins and storage material as patients with FTD due to GRN mutations.
    Davis SE; Cook AK; Hall JA; Voskobiynyk Y; Carullo NV; Boyle NR; Hakim AR; Anderson KM; Hobdy KP; Pugh DA; Murchison CF; McMeekin LJ; Simmons M; Margolies KA; Cowell RM; Nana AL; Spina S; Grinberg LT; Miller BL; Seeley WW; Arrant AE
    Acta Neuropathol Commun; 2023 Apr; 11(1):70. PubMed ID: 37118844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex vivo MRI and histopathology detect novel iron-rich cortical inflammation in frontotemporal lobar degeneration with tau versus TDP-43 pathology.
    Tisdall MD; Ohm DT; Lobrovich R; Das SR; Mizsei G; Prabhakaran K; Ittyerah R; Lim S; McMillan CT; Wolk DA; Gee J; Trojanowski JQ; Lee EB; Detre JA; Yushkevich P; Grossman M; Irwin DJ
    Neuroimage Clin; 2022; 33():102913. PubMed ID: 34952351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein L1 is increased in frontotemporal lobar degeneration post-mortem brain but not in ante-mortem cerebrospinal fluid.
    Hok-A-Hin YS; Dijkstra AA; Rábano A; Hoozemans JJ; Castillo L; Seelaar H; van Swieten JC; Pijnenburg YAL; Teunissen CE; Del Campo M
    Neurobiol Dis; 2022 Oct; 172():105813. PubMed ID: 35820647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TDP-43-associated atrophy in brains with and without frontotemporal lobar degeneration.
    Buciuc M; Martin PR; Tosakulwong N; Murray ME; Petrucelli L; Senjem ML; Spychalla AJ; Knopman DS; Boeve BF; Petersen RC; Parisi JE; Reichard RR; Dickson DW; Jack CR; Whitwell JL; Josephs KA
    Neuroimage Clin; 2022; 34():102954. PubMed ID: 35168140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain DNA methylomic analysis of frontotemporal lobar degeneration reveals OTUD4 in shared dysregulated signatures across pathological subtypes.
    Fodder K; Murthy M; Rizzu P; Toomey CE; Hasan R; Humphrey J; Raj T; Lunnon K; Mill J; Heutink P; Lashley T; Bettencourt C
    Acta Neuropathol; 2023 Jul; 146(1):77-95. PubMed ID: 37149835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TDP-43 subtypes are associated with distinct atrophy patterns in frontotemporal dementia.
    Rohrer JD; Geser F; Zhou J; Gennatas ED; Sidhu M; Trojanowski JQ; Dearmond SJ; Miller BL; Seeley WW
    Neurology; 2010 Dec; 75(24):2204-11. PubMed ID: 21172843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degeneration.
    Cervantes González A; Irwin DJ; Alcolea D; McMillan CT; Chen-Plotkin A; Wolk D; Sirisi S; Dols-Icardo O; Querol-Vilaseca M; Illán-Gala I; Santos-Santos MA; Fortea J; Lee EB; Trojanowski JQ; Grossman M; Lleó A; Belbin O
    Mol Neurodegener; 2022 Apr; 17(1):29. PubMed ID: 35395770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Movement disorders are linked to TDP-43 burden in the substantia nigra of FTLD-TDP brain donors.
    Fiondella L; Gami-Patel P; Blok CA; Rozemuller AJM; Hoozemans JJM; ; Pijnenburg YAL; Scarioni M; Dijkstra AA
    Acta Neuropathol Commun; 2023 Apr; 11(1):63. PubMed ID: 37046309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain progranulin expression in GRN-associated frontotemporal lobar degeneration.
    Chen-Plotkin AS; Xiao J; Geser F; Martinez-Lage M; Grossman M; Unger T; Wood EM; Van Deerlin VM; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2010 Jan; 119(1):111-22. PubMed ID: 19649643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frontotemporal lobar degeneration targets brain regions linked to expression of recently evolved genes.
    Pasquini L; Pereira FL; Seddighi S; Zeng Y; Wei Y; Illán-Gala I; Vatsavayai SC; Friedberg A; Lee AJ; Brown JA; Spina S; Grinberg LT; Sirkis DW; Bonham LW; Yokoyama JS; Boxer AL; Kramer JH; Rosen HJ; Humphrey J; Gitler AD; Miller BL; Pollard KS; Ward ME; Seeley WW
    Brain; 2024 Sep; 147(9):3032-3047. PubMed ID: 38940350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frontotemporal lobar degeneration with TAR DNA-binding protein 43 (TDP-43): its journey of more than 100 years.
    Carlos AF; Josephs KA
    J Neurol; 2022 Aug; 269(8):4030-4054. PubMed ID: 35320398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneous ribonuclear protein E2 (hnRNP E2) is associated with TDP-43-immunoreactive neurites in Semantic Dementia but not with other TDP-43 pathological subtypes of Frontotemporal Lobar Degeneration.
    Davidson YS; Robinson AC; Flood L; Rollinson S; Benson BC; Asi YT; Richardson A; Jones M; Snowden JS; Pickering-Brown S; Lashley T; Mann DMA
    Acta Neuropathol Commun; 2017 Jun; 5(1):54. PubMed ID: 28666471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuron loss and degeneration in the progression of TDP-43 in frontotemporal lobar degeneration.
    Yousef A; Robinson JL; Irwin DJ; Byrne MD; Kwong LK; Lee EB; Xu Y; Xie SX; Rennert L; Suh E; Van Deerlin VM; Grossman M; Lee VM; Trojanowski JQ
    Acta Neuropathol Commun; 2017 Sep; 5(1):68. PubMed ID: 28877758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frontotemporal lobar degeneration proteinopathies have disparate microscopic patterns of white and grey matter pathology.
    Giannini LAA; Peterson C; Ohm D; Xie SX; McMillan CT; Raskovsky K; Massimo L; Suh E; Van Deerlin VM; Wolk DA; Trojanowski JQ; Lee EB; Grossman M; Irwin DJ
    Acta Neuropathol Commun; 2021 Feb; 9(1):30. PubMed ID: 33622418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Event-based modeling of T1-weighted MRI is related to pathology in frontotemporal lobar degeneration due to tau and TDP.
    Olm CA; Burke SE; Peterson C; Lee EB; Trojanowski JQ; Massimo L; Irwin DJ; Grossman M; Gee JC
    Neuroimage Clin; 2023; 37():103285. PubMed ID: 36508888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shared brain transcriptomic signature in TDP-43 type A FTLD patients with or without GRN mutations.
    Pottier C; Mateiu L; Baker MC; DeJesus-Hernandez M; Teixeira Vicente C; Finch NA; Tian S; van Blitterswijk M; Murray ME; Ren Y; Petrucelli L; Oskarsson B; Biernacka JM; Graff-Radford NR; Boeve BF; Petersen RC; Josephs KA; Asmann YW; Dickson DW; Rademakers R
    Brain; 2022 Jul; 145(7):2472-2485. PubMed ID: 34918030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNAs in TDP-43 and FUS/TLS-related frontotemporal lobar degeneration (FTLD).
    Lourenco GF; Janitz M; Huang Y; Halliday GM
    Neurobiol Dis; 2015 Oct; 82():445-454. PubMed ID: 26220395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.